Cytomegalovirus (CMV) Diagnosis - What You Need to Know About IgM and IgG

Cytomegalovirus (CMV) is a widely existing DNA virus, and infection rates vary among different groups of people. For example, in immunocompetent adults, CMV infections are usually asymptomatic or manifest only as mild flu-like symptoms. However, in people with impaired immune systems, such as organ transplant patients, HIV/AIDS patients, and pregnant women, CMV infection can lead to serious complications and even life-threatening. Therefore, accurate diagnosis is crucial for managing CMV infections. In the diagnosis of CMV, detection of immunoglobulin M (IgM) and immunoglobulin G (IgG) antibodies plays a key role. IgM antibodies usually appear during acute infections, while IgG antibodies indicate that an individual has been infected with CMV or has developed immunity.

Understand CMV and Its Clinical Impact

• What is CMV?

CMV belongs to the herpesvirus family, a common virus that most people contract at some stage in their lives. Although most healthy individuals may be asymptomatic, people with low immune functions may develop serious diseases.

• How does CMV spread and who is at risk?

CMV is mainly transmitted through contact with the body fluids of infected individuals, including saliva, urine, blood and semen. If a pregnant woman is infected with CMV, she may pass the virus to the fetus, leading to congenital CMV infection, which may cause hearing loss, vision impairment and developmental delays.

• Symptoms and complications of CMV infection

Symptoms of CMV infection may include fever, enlarged lymph nodes, muscle pain and fatigue. In immunocompromised patients, CMV infection can lead to serious diseases such as pneumonia, gastroenteritis and retinitis.

Fig 1. CMV gastritis with focal active and chronic inflammation.¹

Role of IgG and IgM Antibodies in CMV Diagnostics

IgG Antibodies are proteins produced by the immune system in response to infections. IgM and IgG are two types of antibodies that provide critical information about the stage of a CMV infection.

• CMV IgM: Indicates a recent or active CMV infection. These antibodies are the first to appear after exposure to the virus.
• CMV IgG: Indicates past exposure or immunity. These antibodies persist for life and can offer protection against reinfection.

CMV Lab Tests and Diagnostics

Overview of CMV diagnostic methodsThe detection of CMV antibodies is a cornerstone of diagnostic testing. Key methods include:

• CMV antibody testing (IgM and IgG): Measures the levels of IgM and IgG antibodies in the blood.
• PCR testing for viral DNA: Identifies the presence of CMV genetic material, providing confirmation of active infection.

How CMV IgM and IgG tests are performed and interpreted

CMV antibody tests are typically performed using blood samples. Elevated IgM levels suggest recent infection, while the presence of IgG alone often indicates past exposure. Combining IgM and IgG results helps clinicians determine the infection's timing and status.

Interpreting CMV Test Results

• Positive IgG with negative IgM: Indicates a past infection with no current activity.
• Positive IgG with positive IgM: Suggests an active or recent infection.

High IgM levels typically indicate acute infection.Follow-up tests, such as PCR or IgG avidity testing, may be necessary to confirm the diagnosis. Importance of combining IgM and IgG resultsUsing both IgM and IgG results provides a clearer picture of the infection's phase, allowing for more accurate diagnosis and treatment planning.

CMV Diagnostics in Special Populations

CMV diagnostics during pregnancyPregnant women are at heightened risk due to the potential for congenital CMV, which can lead to developmental delays, hearing loss, or other complications in newborns. IgM/IgG testing is critical for early detection and management. CMV testing in immunocompromised individualsIn transplant patients and others with weakened immune systems, CMV can cause severe complications. Regular monitoring through antibody and PCR testing is essential to prevent and manage infections.

Conclusion

Accurate CMV diagnostics, particularly IgM and IgG antibody testing, have become indispensable tools in clinical and research settings. These biomarkers not only assist in identifying the stage of CMV infection but also provide valuable insights into viral pathogenesis and immune responses. For researchers, IgM and IgG data can inform the development of vaccines and antiviral therapies, contributing to long-term control strategies for CMV. Early diagnosis and continuous advancements in testing technologies are essential for enhancing patient outcomes and expanding our understanding of CMV's impact on human health. Clinicians and scientists alike are encouraged to leverage these tools for comprehensive management and innovative research initiatives.

Beyond its role in disease diagnosis, non-IgG antibodies are redefining therapeutic innovation. Leveraging cutting-edge technologies and extensive expertise, Creative Biolabs pioneers the development of high-performance non-IgG antibody products tailored for diverse applications. Our comprehensive custom services are designed to meet the unique needs of researchers delving into non-IgG antibody mechanisms or exploring their therapeutic applications. We warmly welcome you to connect with us for further insights and collaboration opportunities.

Recommended Services

Reference

1. Željka, Večerić-Haler, and Kojc Nika. "Viral infections after kidney transplantation: CMV and BK." Perioperative care for organ transplant recipient. IntechOpen, 2019. Distributed under the Open Access license CC BY 3.0, without modification.

---

• Non-IgG Therapeutic Antibodies Engineering
• Non-IgG Therapeutic Antibodies Discovery
• Production and Purification
• Non-IgG Therapeutic Antibodies Characterization
• Non-IgG Therapeutic Antibodies PK/PD Evaluation
• Developability Improvement

• IgA
• IgE
• IgM
• Assay kits

• Disease Therapy
• Clinical Diagnosis
• Non-IgG Antibody Application for Vaccine Development

• Non-IgG Antibody Related Diseases
• IgE Related Diseases
• Non-IgG Antibody Research Progress
• Non-IgG Antibody Isotypes
• Non-IgG Receptors and Interactions